RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABEO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Abeona Therapeutics Inc. stock price on Monday moving between $6.94 and $7.70
(Updated on Feb 26, 2024)


Buy or Hold candidate since Feb 08, 2024 Gain 42.80% PDF
The Abeona Therapeutics Inc. stock price gained 8.02% on the last trading day (Monday, 26th Feb 2024), rising from $6.98 to $7.54. During the last trading day the stock fluctuated 11.03% from a day low at $6.94 to a day high of $7.70. The price has risen in 6 of the last 10 days and is up by 21.61% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 394 thousand more shares were traded than the day before. In total, 637 thousand shares were bought and sold for approximately $4.80 million.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $6.67, a level that may pose a second chance to hit a runner. According to fan-theory $8.84 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

ABEO Signals & Forecast

The Abeona Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.89 and $5.48. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, January 31, 2024, and so far it has risen 85.26%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Maximize Your Market Edge: Go Premium for In-Depth AI-Powered Stock Research and Exclusive Lists! 🚀

Support, Risk & Stop-loss for Abeona Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $6.48 and $6.31. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Abeona Therapeutics Inc. finds support just below today's level at $6.48. If this is broken, then the next support from accumulated volume will be at $6.31 and $6.20.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.765 between high and low, or 11.03%. For the last week, the stock has had daily average volatility of 10.23%.

The Abeona Therapeutics Inc. stock is extremely overbought on RSI14 (86). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $7.29 (-3.28%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 86 and this increases the risk substantially. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (ABEO) For The Upcoming Trading Day Of Tuesday 27th

For the upcoming trading day on Tuesday, 27th we expect Abeona Therapeutics Inc. to open at $7.39, and during the day (based on 14 day Average True Range), to move between $7.03 and $8.05, which gives a possible trading interval of +/-$0.512 (+/-6.79%) up or down from last closing price. If Abeona Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 13.57% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $6.48, some $1.06 (14.06%) from the current price of $7.54, our system finds the risk reward attractive.

Is Abeona Therapeutics Inc. stock A Buy?

Abeona Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Open Broker Account

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Hold/Accumulate Downgraded

Predicted Opening Price for Abeona Therapeutics Inc. of Tuesday, February 27, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price February 27, 2024 Current price
$7.39 ( 1.97%) $7.54

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.16 8.18 %
R2 7.86 4.30 %
R1 7.68 1.91 %
Current price: 7.54
Support S1 7.10 -5.84 %
S2 6.92 -8.24 %
S3 6.63 -12.11 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 7.54
Support S1 6.48 -14.06%
S2 6.31 -16.31%
S3 6.20 -17.77%
What is the symbol for Abeona Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Abeona Therapeutics Inc. is ABEO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Abeona Therapeutics Inc. Stock?
Abeona Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Abeona Therapeutics Inc. Stock?
Abeona Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Abeona Therapeutics Inc. Stock.

What's the current price of Abeona Therapeutics Inc. Stock?
As of the end of day on the 2024-02-26, the price of an Abeona Therapeutics Inc. (ABEO) share was $7.54.

What is the 52-week high and low for Abeona Therapeutics Inc. Stock?
The 52-week high for Abeona Therapeutics Inc. Stock is $7.70 and the 52-week low is $2.21.

What is the market capitalization of Abeona Therapeutics Inc. Stock?
As of the 2024-02-26, the market capitalization of Abeona Therapeutics Inc. is 172.918M.

When is the next earnings date for Abeona Therapeutics Inc.?
The upcoming earnings date for Abeona Therapeutics Inc. is Mar 27, 2024.

Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT